bioAffinity Technologies, Inc. (BIAF) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending September 2025, bioAffinity Technologies, Inc. (NASDAQ:BIAF) is held by 13 institutional firms.

• Institutional ownership in bioAffinity Technologies edged up to 31.8% in September 2025, compared to 1.3% in June 2025.
• Quarterly data indicates a 36126.34% shift in institutional share volume, and the annual owner count reflects a decrease of 7.14%.
• The latest 13F cycle for bioAffinity Technologies reveals that of 13 total investors, 13 funds grew their exposure, whereas 0 reduced theirs and 0 made no changes.
• Collectively, institutional investors increased their stake in bioAffinity Technologies to 301.86K shares as of September 2025, a change that is up by 301.02K shares quarter on quarter and up 286.26K shares year over year.
• SABBY MANAGEMENT, LLC continues to be the largest institutional holder of bioAffinity Technologies as of September 30, 2025, with a position of 242.76K shares, representing 25.58% of the company's outstanding stock.
• Among the most significant buyers of bioAffinity Technologies during September 2025 were SABBY MANAGEMENT, LLC (242.76K), IFP Advisors, Inc (24.17K), Scientech Research LLC (16.58K), VANGUARD GROUP INC (10.43K), Tower Research Capital LLC (TRC) (2.50K).
• The top 10 institutional holders of bioAffinity Technologies for the quarter ending September 2025 included SABBY MANAGEMENT, LLC (242.76K), IFP Advisors, Inc (25.00K), Scientech Research LLC (16.58K), VANGUARD GROUP INC (10.43K), Tower Research Capital LLC (TRC) (2.50K), Allworth Financial LP (1.79K), BANK OF AMERICA CORP /DE/ (1.68K), IFP Advisors, Inc (833), UBS Group AG (143), CITIGROUP INC (75).